The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $73.16

Today's change+1.06 +1.47%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $73.16

Today's change+1.06 +1.47%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Endo International PLC up (U.S.)$1.06

Endo International PLC closed up Friday by (U.S.)$1.06 or 1.47% to (U.S.)$73.16. Over the last five days, shares are unchanged, but have gained 8.45% over the last year to date. This security has underperformed the S&P 500 by 4.30% during the last year.

Key company metrics

  • Open(U.S.) $72.73
  • Previous close(U.S.) $72.10
  • High(U.S.) $73.43
  • Low(U.S.) $72.21
  • Bid / Ask-- / --
  • YTD % change+8.45%
  • Volume603,449
  • Average volume (10-day)1,755,929
  • Average volume (1-month)1,551,239
  • Average volume (3-month)2,080,887
  • 52-week range(U.S.) $53.62 to (U.S.) $82.16
  • Beta1.20
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.29×
  • Forward PEG4.30×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$11.05
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-53.19%

Endo International PLC has a net profit margin of -53.19%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue764719595427
Total other revenue--------
Total revenue764719595427
Gross profit385373343270
Total cost of revenue379346252156
Total operating expense1,0986341,2011,144
Selling / general / administrative205172227160
Research & development31414229
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)48276681799
Other operating expenses, total--------
Operating income-33485-607-717
Interest income (expense), net non-operating-62-53-54-44
Gain (loss) on sale of assets--------
Other--------
Income before tax-39139-654-762
Income after tax-25224-439-665
Income tax, total-13916-215-97
Net income-25221-437-776
Total adjustments to net income--------
Net income before extra. items-25224-442-626
Minority interest01-439
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-25224-442-626
Inc. avail. to common incl. extra. items-25221-437-776
Diluted net income-25221-437-776
Dilution adjustment--------
Diluted weighted average shares153163128103
Diluted EPS excluding extraordinary itemsvalue per share-1.640.15-3.45-6.11
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.430.470.00-1.04